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A B S T R A C T
Background
While the aims of multicomponent screening of older people are broad, any benefit arising from the inclusion of a vision component
in the assessment will necessarily be dependent on improving vision.
Objectives
To assess the effects on vision of mass screening of older people for visual impairment.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group
Trials Register) (The Cochrane Library, Issue 1, 2008), MEDLINE (1966 to February 2008), EMBASE (1980 to February 2008),
PubMed (on 8th March 2006; last 90 days), UK Clinical Trials Gateway on 29 February 2008, SciSearch and reference lists of relevant
trial reports and review articles. We contacted investigators to identify additional published and unpublished trials.
Selection criteria
We included randomised trials of visual or multicomponent screening for identifying vision impairment in people aged 65 years or
over in a community setting.
Data collection and analysis
Both authors independently extracted data and assessed trial quality.
Main results
Visual outcome data were available for 3494 people in five trials of multicomponent assessment. Length of follow up ranged from
two to four years. All the trials used self-reported measures for visual impairment, both as screening tools and as outcome measures.
In four of the trials people reporting visual problems were referred to either eye services or a physician. In one trial people reporting
visual problems received information about resources in the community designed to assist those with poor vision. The proportions of
participants in the intervention and control groups who reported visual problems at the time of outcome assessment were 0.26 and
0.23 respectively (risk ratio for visual impairment 1.03, 95% confidence interval (CI) 0.92 to 1.15). Visual outcome data were also
available for 1807 people aged 75 years and over in a cluster randomised trial in which physicians’ general practices were randomised
to two different screening strategies; universal or targeted. Three to five years after screening, the risk ratio for visual acuity less than 6/
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18 in either eye comparing universal with targeted screening was 1.07 (95% CI 0.84 to 1.36, P = 0.58). The mean composite score
of the National Eye Institute 25 item visual function questionnaire was 85.6 in the targeted screening group and 86.0 in the universal
group, a difference of 0.4 (95% CI -1.7 to 2.5, P = 0.69).
Authors’ conclusions
There is no evidence that community-based screening of asymptomatic older people results in improvements in vision.
P L A I N L A N G U A G E S U M M A R Y
Community screening for visual impairment in the elderly
Visual impairment is common among older people and is associated with falls and reduced quality of life. Visual problems in older
people are often not reported to medical services. Screening has been recommended because vision could be improved by encouraging
treatment in the majority of older people with impaired vision. The review found five studies in which vision was tested as part of a
broader screening assessment. No improvement in vision was seen two to four years after screening compared to elderly people who
were not screened. This may be due to the lack of a clear plan of intervention for visual problems found on screening. In another study,
the risk of having visual impairment in either eye was similar with universal and targeted screening, three to five years after screening.
B A C K G R O U N D
Health services for older people are of increasing importance. In
promoting health for older people, in recent years there has been
a change in emphasis away from a medically-orientated approach
and towards an approach which focuses on the improvement of
functional ability and quality of life (Rubenstein 1989; Williams
1993). Improving sensory function is central to this approach.
A number of community surveys have demonstrated high levels
of visual impairment among older people (Klein 1991; Wormald
1992), much of which could potentially be improved by treat-
ment. A variety of adverse factors have been reported in associa-
tion with visual impairment including: reduced functional status,
social interaction and quality of life; depression; and falls.
Multicomponent assessment of older people was originally devel-
oped in the United Kingdom (Williamson 1964) and has been
introduced in many countries. Multicomponent assessment aims
to determine an older person’s medical, social, psychological and
functional problems, and to form a plan for treatment and follow
up. Most forms of this assessment include some attempt to assess
vision. Whilemulticomponent assessment has been shown to pro-
duce some small overall benefits (Stuck 1993), exactly which pro-
cedures within the assessment are effective and which are ineffec-
tive is uncertain. Specific screening procedures for chronic open-
angle glaucoma or diabetic retinopathy have not been included in
trials or programmes of multicomponent screening assessments.
Although the aim of improving visual impairment is clearly to
produce improvements in other clinical outcomes, (such as im-
proved quality of life or a reduction in falls), any benefit arising
from vision assessment will necessarily be dependent on improved
vision. Similarly, while the aims of multicomponent screening of
older people are broad any benefit arising from the inclusion of a
vision component in the assessment will necessarily be dependent
on improved vision. Therefore, this review used improvement in
vision as the outcome measure of interest.
O B J E C T I V E S
The objective of this review was to assess the effects on vision of
mass screening of older people for visual impairment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised trials of visual screening alone or as
part of multicomponent screening in unselected people aged 65
years or over in a community setting.
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Types of participants
Participants in the trials were people aged 65 years or over who
were not identified as belonging to a particular risk group.
Types of interventions
We included trials in which there was any attempt at population
screening for visual impairment in a community setting, either
vision alone or as part of a multicomponent screening assessment.
Types of outcome measures
The outcome included was the level of visual impairment in the
population at the end of the trial. Assessment of vision by any
method (questions about vision, measures of visual function or
use of an acuity chart) at least six months after the initial vision
screening assessment was included.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) (which contains the Cochrane Eyes and Vision
Group Trials Register) (The Cochrane Library, Issue 1, 2008),
MEDLINE (1966 to February 2008), EMBASE (1980 to Febru-
ary 2008), PubMed (on 8th March 2006; last 90 days) and the
UK Clinical Trials Gateway. There were no language or date re-
strictions in the search for trials. The electronic databases were last
searched on 29 February 2008.
See: Appendices for details of search strategies for The Cochrane
Library, MEDLINE, EMBASE, the UK Clinical Trials Gateway
and PubMed.
Searching other resources
We scanned the reference lists of identified trial reports and of
review articles for further relevant reports. We used the SciSearch
database to search for articles that cited the included studies. We
contacted the named author for correspondence for each of the
included trials to obtain information about any other trials.
Data collection and analysis
Selection of studies
Two authors independently assessed the titles and abstracts iden-
tified from the searches and full reports were obtained of studies
which possibly or definitely fulfilled the selection criteria. A vision
screen may have been only one small part of a multicomponent
screening programme and data about vision outcomes may not
have been included in published reports of trials. Therefore, we
contacted trial authors for further information about visual out-
come data if these were not reported. Trial authors were also asked
to provide further details about the screening and outcome as-
sessments and about the interventions offered. Studies for which
vision outcome data were available were selected for quality assess-
ment and data extraction.
Data extraction and management
Two authors independently extracted data about visual outcomes
using paper data extraction sheets. We resolved disagreements by
discussion. The proportions of people with visual impairment in
the experimental and control groups formed the comparison.
Assessment of risk of bias in included studies
Trial quality was assessed based on the recommendations in Sec-
tion 6 of the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2005b). Four parameters were considered; each
parameter of trial quality was graded: A (adequate), B (not clear),
or C (inadequate). The following criteria were used.
(1) Allocation concealment. This was graded A if there was some
form of centralised randomisation scheme, an on-site computer
system or if sequentially-numbered sealed opaque envelopes were
used.
(2) Attrition bias. This was graded A if follow-up rates were similar
in the comparison groups.
(3) Intention-to-treat analysis. This was graded A if performed.
(4) Masking of outcome assessment. This was graded A if the
outcome assessors were masked to the allocation.
Because of the nature of the intervention it would not have been
possible to mask either recipients or providers of care to their
allocation and, therefore, this was not used as quality parameters
for this review.
Two authors assessed trial quality; disagreements were resolved by
discussion. Authors were not masked to the report authors or trial
results. For any trial graded B (or C unless an explicit statement
was made about the quality component in the trial report), the
trial authors were contacted for clarification. Trials scoring C on
allocation concealment were excluded.
Data synthesis
Results of studies which were similar with respect to the three
factors outlined above were combined to produce a summary risk
ratio using the fixed-effect Mantel-Haenszel method. A random-
effects model was also used and the results compared to the results
from the fixed-effect model. For cluster randomised trials standard
errors take account of the cluster design. We assessed the amount
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of between study heterogeneity using the I2 statistic and tested for
heterogeneity between trials using a standard chi-squared test.
Sensitivity analysis
Three possible effect modifiers were identified prior to analysis.
Firstly, trials of visual screening alonemight be expected to produce
a different effect to trials of visual screening included in a broader
assessment. Itwas decided that these two sub-groups of trialswould
be analysed separately because a pooled result would be difficult to
interpret. Secondly, it is known that questions about vision, formal
assessment using an acuity chart, and measures of visual function
differ in their sensitivity and specificity for detecting reduced visual
acuity, and use of different types of screening tools may lead to
differences in the effects of screening (Smeeth 1998a). Thirdly,
differences in trial quality may produce differences in the effect
size seen. We planned sensitivity analyses to assess the effects of
including or excluding trials which differed in these characteristics.
We also planned an exploration of any difference in effect size
according to the screening tool used or trial quality.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
The initial searches found 2862 citations and abstracts. Of these
154 full text articles were reviewed in detail. Five trials met the
final inclusion criteria, that is, visual outcome data were available
with follow up of at least six months. There were no trials that
were primarily of visual screening.
Subsequent searches, conducted inFebruary 2006, identified 1269
titles and abstracts. There was one new trial relevant for inclusion
in this review (Smeeth 2003). This was a cluster randomised trial.
A further update searchwas done in February 2008. The electronic
searches retrieved 8 references from The Cochrane Library, 277
references from MEDLINE, 363 references from EMBASE and
26 references from the UK Clinical Trials Gateway. After dedu-
plication the search identified a total of 561 references.The Trials
Search Co-ordinator scanned the search results and removed any
references which were not relevant to the scope of the review. One
report (Tay 2006 ) was identified as being potentially relevant,
however, further information is required from the authors prior
to this study being assessed for inclusion in the review.
Included studies
The following is a broad description of the included studies. See
table: ’Characteristics of included studies’ for more detailed infor-
mation on the individual trials.
Setting and participants
The five individually randomised trials included a total of 3494
participants. The cluster randomised trial included 4340 partic-
ipants (Smeeth 2003). Four of the studies were undertaken in
the United Kingdom (McEwan 1990; Smeeth 2003; Vetter 1984;
Vetter 1992), all of which recruited participants from general prac-
tice (family practice). One study was undertaken in The Nether-
lands (VanRossum 1993) and recruited from a defined geographic
area. One study was undertaken in the United States (Wagner
1994) and recruited from a health maintenance organisation.
Interventions
In all trials visual screening was undertaken as part of a broader
assessment of health and functioning. In Wagner 1994 the as-
sessments were undertaken at a clinic. In Smeeth 2003 33.9% of
screening assessments were undertaken in peoples’ own homes, the
remainder being undertaken at the general practice surgery. In the
remaining trials the assessments were undertaken in participants’
homes. In Smeeth 2003, visual acuity screening was offered to all
participants in one arm of the trial and was compared with tar-
geted screening in which only participants with a range of health
related problems were offered an assessment including visual acu-
ity screening. The remaining five trials used questions about vision
for the screening assessment. They did not measure vision. Assess-
ments in all trials were undertaken by specially trained nurses or
health visitors.
Outcome measures
In Smeeth 2003 visual acuity was assessed and a 25 item version
of theNational Eye Institute Visual Function Questionnaire (NEI
VFQ-25) (Mangione 2001) completed. The remaining five trials
used questions about vision to assess visual outcome. In Wagner
1994 visual outcome was assessed as part of a postal questionnaire.
In the other four trials the outcome assessment was by face to
face interview. Length of follow up ranged from two to four years,
except in Smeeth 2003 where the range was three to five years.
Excluded studies
Sixteen trials were excluded from this review and reasons for ex-
clusion are given in the table: ’Characteristics of excluded studies’.
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Risk of bias in included studies
Allocation concealment
All six trials were graded A. Descriptions of the randomisation
process were obtained for all six trials. Randomisation was under-
taken centrally in all trials using random number tables or random
number generators.
Attrition bias
Because of the ages of the trial participants there was a high mor-
tality rate inmost of the trials. In Smeeth 2003 around one third of
participants died prior to outcome assessment. Excluding people
who had died, the overall response rate was 62.8%. However, there
was a difference between the two arms. The response rate to follow
up among those still alive was 67.8% (978/1443) in the targeted
screening group and 57.9% (829/1432) in the universal screening
group. This was a possible source of bias and the trial was thus
graded C. Follow-up rates were similar between the comparison
groups in the remaining five trials and all were graded A.
Intention-to-treat analysis
All six trials were analysed by intention-to-treat and were graded
A; that is participants with outcome data available were analysed
in the groups to which they were originally randomised.
Masking of outcome assessment
The trial participants would clearly have been aware of whether
they had received a screening assessment. Thus, in spite of at-
tempts to mask the outcome assessors, which arm of the trial par-
ticipants were in could have emerged during the face to face out-
come assessments. This phenomenon was noted to a small degree
in Vetter 1984 and Vetter 1992. Predicting that this phenomenon
was likely, such masking was considered impossible in McEwan
1990. In Van Rossum 1993 and Smeeth 2003 outcome assessors
were masked as far as possible. Postal questionnaires to partici-
pants were used to assess outcomes in Wagner 1994.
Effects of interventions
The results in all five trials in which individuals were randomised
were very similar. There was no evidence of heterogeneity of effect
between the five trials (I2 was 0%, χ2 = 0.88, df = 4, P = 0.93). The
pooled risk ratio for people in the intervention and control groups
having self-reported visual problems when outcome assessments
were performed was 1.03 (95% confidence interval (CI) 0.92 to
1.15). The pooled odds ratio was 1.04 (95% CI 0.89 to 1.22). In
the cluster randomised trial (Smeeth 2003), analysis took account
of the clustered design. Three to five years after screening, the
risk ratio for visual acuity less than 6/18 in either eye comparing
universal with targeted screening, was 1.07 (95% CI 0.84 to 1.36,
P = 0.58). The mean composite score of the NEI VFQ-25 was
85.6 in the targeted screening group and 86.0 in the universal
group, difference 0.4 (95% CI -1.7 to 2.5, P = 0.69).
Only one trial (Smeeth 2003) differed in any of the aspects identi-
fied a priori as possible effect modifiers (visual assessment method
used for screening, visual outcome used) but it was similar to all the
remaining trials for the other aspects identified a priori ( whether
visual screening was undertaken as part of a wider screening as-
sessment, and trial quality). However, in spite of the differences
between Smeeth 2003 and the other five trials, the results obtained
were remarkably similar.
D I S C U S S I O N
Visual impairment is common among older people and is fre-
quently unreported. It has several adverse associations including
falls, reduced quality of life and reduced functional ability (Smeeth
1998a). Results from community surveys in the over 75 years age
group suggest that over half the visual impairment in this age group
could potentially be reduced with treatment, notably by cataract
surgery or refractive correction (Klein 1991; Wormald 1992). In
light of this, the lack of improvement seen in these trials is some-
what surprising and cannot be explained with any certainty from
the data available.
Possible explanations for lack of effectiveness
A number of factors may have contributed. Firstly, the visual as-
sessment was only one component of the screening package in all
six trials. It is possible that visual screening performed in isolation
may have produced a greater effect. This hypothesis was previously
suggested as an explanation of the lack of effectiveness of screening
for visual impairment seen in a trial of amulticomponent screening
assessment among middle-aged men (SLSSG 1977; Stone 1978).
However, in clinical practice screening for visual impairment is
highly likely to be one part of a broader screening package and,
therefore, an assessment of effectiveness within a broader package
is the most pragmatically useful measure.
Secondly, a screening procedure alone would not be expected to
lead to improvements in vision. Such improvements would be de-
pendent on the subsequent interventions to improve vision. In
four of the trials (McEwan 1990; Van Rossum 1993; Vetter 1984;
Vetter 1992) those reporting visual problems were given advice
and referred to either an optometrist or their general practitioner.
In Wagner 1994 those reporting problems received information
about resources in the community that were designed to assist
those with poor vision. In Smeeth 2003, participants with a pin-
hole vision of less than 6/18 in either eye were referred to an oph-
thalmologist unless they were registered blind or had seen by an
ophthalmologist in the previous year. Participants with present-
ing vision of less than 6/18 in either eye that improved with a
pinhole to better than 6/18 were advised to see an optician. In
Smeeth 2003, high levels of visual impairment were found among
participants: almost 29% had a visual acuity less than 6/18 in ei-
ther eye. In spite of a high level of glasses ownership, 17.5% peo-
ple with visual impairment had evidence of uncorrected refractive
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error. The level of uncorrected refractive error would have been
under-estimated because many eligible people did not complete a
pinhole assessment, largely because of difficulties using a pinhole
occluder in this age group. Among people in whom refractive er-
ror was diagnosed, around half obtained new glasses and the level
of uncorrected refractive error was reduced. For people with vi-
sual impairment not thought to be due to refractive error, 35%
had seen an ophthalmologist in the past 12 months and a further
14% were registered blind or partially sighted. Both these groups
were not eligible for referral. Only around half of those people
recommended for referral to an ophthalmologist were actually re-
ferred; although when referral did occur, attendance at eye clinics
was high. People with worse vision were more likely to be referred
and people with evidence of cognitive impairment at the time of
screening were less likely to be referred. However, explanations for
the low adherence by general practitioners to recommendations
for referral are lacking. Around half of those who attended an oph-
thalmologist following screening had cataract surgery and their
vision improved. Among the remaining people who attended an
ophthalmologist following screening, there was no improvement
in visual acuity. It is possible that some of these people received in-
terventions for low vision that were of benefit in terms of function
and quality of life, but that would not be expected to improve vi-
sual acuity. However, the result for visual function did not differ in
the two trial arms. The study authors concluded that while overall
as a result of the visual screening some people obtained beneficial
interventions, the numbers of people benefiting was small in the
context of a population-based screening programme and were not
sufficient to affect the prevalence of visual impairment among all
participants. For the remaining trials, no information was avail-
able about whether participants attended the referrals; diagnoses
made; and interventions offered and accepted.
A third factor whichmay have contributed to the lack of effect seen
is that individuals who reported visual problems when prompted
to do so in a screening programme may not have perceived their
previously unreported visual impairment as a ’need’ for interven-
tion. Gradual adjustment to and assimilation of reduced visual
functionmay occur with ageing among some people. Therefore, in
spite of reporting problems with vision when asked directly, they
may not have acted on advice to seek further care. There is very
little information on whether older people accept interventions
for visual problems discovered by screening. In a randomised trial
of multicomponent screening in the United States 15 out of 18
older people complied with advice to attend for an eye examina-
tion (Fabacher 1994). In aUnitedKingdomgeneral practice-based
survey one third of those referred to the eye services with a visual
problem did not attend (Wormald 1992). In addition to partic-
ipants not concurring with the need for intervention, there may
have been barriers to obtaining help with the eye problems iden-
tified. Possible barriers include: costs of further eye tests, glasses
and other treatments; and an inability of ophthalmic services to
meet demand, for example for cataract extraction.
Finally, the use of questions about vision both for the initial screen-
ing assessment and for the outcome assessment may have affected
the results in five of the trials. Questions about vision have a low
sensitivity, and to a lesser extent, a low specificity for detecting vi-
sual impairment when compared to formal acuity testing (Smeeth
1998a). However, in the one trial that measured visual acuity both
at the screening assessment and at the outcome assessment, the
lack of effect of screening on visual outcomes was very similar to
the results seen in the remaining trials.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from randomised controlled trials undertaken to
date does not support the inclusion of a visual screening compo-
nent in multidimensional screening programmes for older people
in a community setting. The reasons for the lack of effect seen in
these trials are unclear. However, it seems likely that before popu-
lation screening can be effective existing obstacles to reducing vi-
sual impairment among older people, once it has been discovered,
may need to be overcome.
In five of the trials included in this review, questions about visual
problems were used, both for the visual screening assessment and
for the assessment of visual outcomes. However, in the one trial
that used visual acuity for screening, and measured both visual
acuity and visual function at outcome assessment, a similar lack
of improvement in vision as a result of screening was observed.
There are no data from trials to assess the effects of screening older
people for visual impairment alone and, therefore, no recommen-
dation can be made on this issue.
Implications for research
Given the importance of visual impairment among older people,
further research into strategies to improve vision of older people
is needed. The effectiveness of an optimised primary care-based
screening intervention that overcomes possible factors contribut-
ing to the observed lack of benefit in trials to date warrants assess-
ment.
There are a number of unresolved issues around optimal tools to
be used for screening for visual impairment, particularly in the
context of multidimensional screening in primary care. If primary
care teams are to be expected to detect refractive error, better meth-
ods of diagnosis which can be completed by a higher proportion of
the older population than the pinhole assessment will be needed.
Whether visual acuity is a good screening tool to identify people
who are likely to benefit from interventions to improve their vi-
sion needs to be assessed. The value of screening for other mea-
sures such as visual fields or contrast sensitivity warrants further
work. While single questions about self-reported visual difficulties
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are poor predictors of low visual acuity, the development of brief
screening instruments that assess visual function could be of great
value (Iliffe 2005).
With regards to multidimensional assessment for older people, in
the one trial with data on this issue the low level of ophthalmo-
logical referrals for those people deemed eligible for referral fol-
lowing screening was notable. There is scope for more research
on the determinants of clinician adherence to recommendations
for referrals arising from multidimensional assessments. Specific
issues of interest are assessing the appropriateness of the referral
decisions made and the role of the patient in the decision whether
to refer or not.
The effectiveness of an increased role for optometry services in
the detection and management of visual problems among older
people on a population basis warrants evaluation.
Detailed prospective research on the detection, referral, diagnosis
and management of visual problems in older people could help
shed further light on the reasons for the ineffectiveness of screen-
ing. As well as looking at health service issues, research from the
perspective of the older people themselves is also needed. Areas
which particularly need to be addressed include: older peoples’
perceptions of their visual problems and of the need for interven-
tions; and perceived barriers to interventions to help their vision.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
McEwan 1990
Methods Randomised: random number generator, centrally
Stratified by age: 75 to 84, 85+
Masking: outcome assessors not masked
Participants Geographic region: United Kingdom
All people registered with a general practice
Age: over 75
Exclusion criteria: too ill for assessment or in hospital (11)
Prior to randomisation all participants interviewed regarding mental and physical health and functioning,
including questions about vision
N = 296
Interventions (1) Multicomponent home nurse assessment (including social functioning, current medical problems
and additional question about vision). Those reporting visual problems given advice and referred to an
optometrist (n = 151)
(2) Usual care (n = 145)
Follow-up period: 20 months
Outcomes Proportion who ’always’ or ’quite often’ had difficulty reading ordinary newsprint (with glasses if worn)
Attrition: outcome data available on 78% of participants in intervention group (16 deaths and 17 lost to
follow up) and 77% in control group (23 deaths and 11 lost to follow up)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Smeeth 2003
Methods Centralised cluster computer generated randomisation of general practices
Participants Geographic region: United Kingdom
A random sample of 220 people registered with each general practice and eligible for trial entry
Age: over 75
Exclusion criteria: terminal illness or resident in a long-stay hospital or nursing home
20 practices randomised, with a total of 4340 participants
Interventions Partcipants were randomised to one of two screening strategies
(1) Universal screening group: all trial participants were invited to complete a brief assessment followed by
a detailed health assessment by a trained nurse that included measurement of visual acuity on the logMAR
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Smeeth 2003 (Continued)
scale using a Glasgow acuity chart. People with visual acuity less than 6/18 in either eye hadmeasurements
repeated using a pinhole occluder. Participants with a pinhole vision of less than 6/18 in either eye were
referred to an ophthalmologist unless they were registered blind or had seen an ophthalmologist in the
previous year. Participants presenting with vision of less than 6/18 in either eye that improved with pinhole
to better than 6/18 were advised to see an optician
N = 2140 randomised. 1565 had an assessment, response rate 73.1%
(2) Targeted screening group: participants were invited to complete a brief screening assessment that
included a question about difficulty seeing. Only people found to have a pre-specified range and level of
problems during the brief assessment were invited to have a detailed assessment including visual acuity
N = 2200 randomised. 1684 had an assessment, response rate 76.5%
120 people out of the 1684 who had a brief assessment went on to have visual acuity measured
Follow-up period: 3 to 5 years
Outcomes Visual acuity less than 6/18 in either eye and mean composite score of the NEI VFQ-25 comparing
universal with targeted screening
A total of 1807 outcome assessments were completed. Around one third of participants died prior to
outcome assessment. Excluding people who had died the response rate was 67.8% (978/1443) in the
targeted group and 57.9% (829/1432) in the universal screening group
Notes Cluster randomised
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Van Rossum 1993
Methods Randomised: random numbers generator, centrally
Stratified prior to randomisation by sex, self-rated health, composition of household and neighbourhood
(as a marker of social class)
Masking: outcome assessors masked
Participants Geographic region: Netherlands
All people living at home in a geographically defined area were sent a postal invitation
Age: 75 to 84
Exclusion criteria: people already receiving home nursing care or their partners (126); people living in a
monastery (20)
N = 580
Interventions (1) Four visits per year for 3 years by trained nurses. One question about vision: ’How do you assess your
vision at present?’ Possible answers: excellent, good, fair, not so good or bad. Those answering ‘fair’, ’not
so good’ or ‘bad’ to the screening question advised to contact an optometrist (n = 292)
(2) Usual care, no screening (n = 288)
Follow-up period: 3 years
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Van Rossum 1993 (Continued)
Outcomes Proportion answering ‘fair’, not so good’ or ‘bad’ to the screening question at the end of the study
Attrition: outcome data available on 79% of participants in intervention group (42 deaths and 19 lost to
follow up) and 77% in control group (50 deaths and 17 lost to follow up)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vetter 1984
Methods Randomised by household: random number tables, centrally. Household randomisation undertaken be-
cause it was felt it would be difficult for the health visitor to intervene on behalf of one member of a
household and not for another
Masking: outcome assessors masked
Participants Geographic region: United Kingdom
People living at home registered with two general practices
Age: over 70
Exclusion criteria: people in permanent residential care
N = 1148
Interventions (1) Annual assessment at home by a health visitor. Two questions about glasses and difficulty seeing.
Those reporting difficulties seeing were referred to an optometrist or to their general practitioner and were
offered advice from the health visitor (n = 577)
(2) Usual care, no screening (n = 571)
Follow-up period: 2 years
Outcomes Proportion with a positive response to the question ‘Do you have any difficulty seeing (even when wearing
your glasses)’
Attrition: outcome data available on 84% of participants in intervention group (80 deaths and nine lost
to follow up) and 79% in control group (105 deaths and 10 lost to follow up)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Vetter 1992
Methods Randomised: random number tables, centrally. Household randomisation undertaken because part of
intervention included improvements in the home environment
Masking: outcome assessors masked
Participants Geographic region: United Kingdom
People registered with one general practice
Age: 75 and over
Exclusion criteria: people excluded by general practitioners because it was felt they were likely to refuse
trial entry (9)
N = 674
Interventions (1) Annual assessment at home by a health visitor, specifically aimed at reducing falls and fractures. Two
questions about glasses and difficulty seeing, and third question about recent eye tests. Those reporting
difficulties seeing were referred to an optometrist or to their general practitioner, and were offered advice
from the health visitor (n = 350)
(2) Usual care, no screening (n = 324)
Follow-up period: 4 years
Outcomes Proportion with a positive response to the question ‘Do you have any difficulty seeing (even when wearing
your glasses)’
Attrition: outcome data available on 69% of participants in intervention group (88 deaths and 22 lost to
follow up) and 65% in control group (106 deaths and eight lost to follow up)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Wagner 1994
Methods Randomised: random number table, independent of trialists or participants
Masking: outcomes assessed by postal questionnaire, no masking
Participants Geographic region: United States
Random sample of health maintenance organisation enrollees
Age: over 65
Exclusion criteria: people in residential care, people too ill to undertake the assessment
N = 1559
Interventions (1) Invited for a multicomponent nurse assessment (including vision) aimed at reducing disability and
falls. Those reporting problems received information about resources in the community designed to assist
those with poor vision (n = 635)
(2) Invited to a general health promotion visit with no visual assessment (n = 317)
(3) Usual care, no screening (n = 607)
Follow-up period: 2 years
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Wagner 1994 (Continued)
Outcomes Proportions reporting visual problems on a mailed questionnaire
Attrition: 5% of total (89), 53 deaths, 18 refusals, 15 too ill, 2 institutionalised, 1 could not be contacted.
Author states attrition evenly distributed across groups
For this review, group 1 (who received a visual screen) has been analysed against groups 2 and 3 together
(who received no visual screen)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
General practice is equivalent to family practice
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Carpenter 1990 No visual outcome data
Clarke 1992 No visual outcome data
Epstein 1990 No visual outcome data
Fabacher 1994 No visual outcome data
Hall 1992 No visual outcome data in report
Hanger 1990 No control group
Hendriksen 1984 No visual outcome data
Pathy 1992 No visual outcome data
Rubenstein 1986 No control group
Sorensen 1988 No visual outcome data
Stone 1978 Participants aged 64 years and under only
Stuck 1995 No visual outcome data
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(Continued)
Tinneti 1994 All participants selected on basis of being at high risk of falling
No visual outcome data
Tulloch 1979 No visual outcome data
Williams 1987 No visual outcome data
Yeo 1987 No visual outcome data
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D A T A A N D A N A L Y S E S
Comparison 1. VISUAL SCREENING AS PART OF A MULTICOMPONENT SCREENING PACKAGE VERSUS
STANDARD CARE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Not seeing well (as defined by
each trial)
5 3494 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.92, 1.15]
Comparison 2. UNIVERSAL VISUAL ACUITY SCREENING AS PART OF A MULTICOMPONENT SCREEN-
ING PACKAGE VERSUS TARGETED SCREENING
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Visual acuity less than 6/18 in
either eye
Other data No numeric data
2 Mean composite visual function
score (VFQ-25)
Other data No numeric data
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Analysis 1.1. Comparison 1 VISUAL SCREENING AS PART OF A MULTICOMPONENT SCREENING
PACKAGE VERSUS STANDARD CARE, Outcome 1 Not seeing well (as defined by each trial).
Review: Community screening for visual impairment in the elderly
Comparison: 1 VISUAL SCREENING AS PART OF A MULTICOMPONENT SCREENING PACKAGE VERSUS STANDARD CARE
Outcome: 1 Not seeing well (as defined by each trial)
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
McEwan 1990 21/118 19/111 4.7 % 1.04 [ 0.59, 1.83 ]
Van Rossum 1993 99/231 87/221 21.3 % 1.09 [ 0.87, 1.36 ]
Vetter 1984 161/486 141/453 34.9 % 1.06 [ 0.88, 1.28 ]
Vetter 1992 75/240 68/207 17.5 % 0.95 [ 0.73, 1.25 ]
Wagner 1994 74/581 111/846 21.6 % 0.97 [ 0.74, 1.28 ]
Total (95% CI) 1656 1838 100.0 % 1.03 [ 0.92, 1.15 ]
Total events: 430 (Intervention), 426 (Control)
Heterogeneity: Chi2 = 0.88, df = 4 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
0.1 0.2 0.5 1 2 5 10
Favours intervention Favours control
Analysis 2.1. Comparison 2 UNIVERSAL VISUAL ACUITY SCREENING AS PART OF A
MULTICOMPONENT SCREENING PACKAGE VERSUS TARGETED SCREENING, Outcome 1 Visual acuity
less than 6/18 in either eye.
Visual acuity less than 6/18 in either eye
Study Universal n Universal N Targeted n Targeted N Relative risk 95% CI P value
Smeeth 2003 307 829 339 978 1.07 0.84 to 1.36 0.58
Analysis 2.2. Comparison 2 UNIVERSAL VISUAL ACUITY SCREENING AS PART OF A
MULTICOMPONENT SCREENING PACKAGE VERSUS TARGETED SCREENING, Outcome 2 Mean
composite visual function score (VFQ-25).
Mean composite visual function score (VFQ-25)
Study Universal screening Targeted screening Difference 95% CI of difference P value
Smeeth 2003 86.0 85.6 0.4 -1.7 to 2.5 0.69
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Vision Screening
#2 MeSH descriptor Vision Tests
#3 (vision or visual*) near5 (screen* or assess* or test* or diagnos* or surveill*)
#4 (#1 OR #2 OR #3)
#5 MeSH descriptor Aged
#6 MeSH descriptor Health Services for the Aged
#7 old* near5 (age* or people or person*)
#8 geriatric* or elderly or senior*
#9 (#5 OR #6 OR #7 OR #8)
#10 MeSH descriptor Eye Diseases
#11 MeSH descriptor Visual Acuity
#12 visual next acuit*
#13 MeSH descriptor Macular Degeneration
#14 macula* next degenerat*
#15 eye* or vision or ophthalmic or glaucom* or cataract* or presbyop*
#16 (#10 OR #11 OR #12 OR #13 OR #14 OR #15)
#17 (#4 AND #9 AND #16)
Appendix 2. MEDLINE search strategy
1. randomized controlled trial.pt.
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. exp animals/
10. exp humans/
11. 9 not (9 and 10)
12. 8 not 11
13. exp vision screening/
14. exp vision tests/
15. ((vision or visual$) adj5 (screen* or assess* or test* or diagnos* or surveill*)).tw.
16. or/13-15
17. exp aged/
18. “Aged, 80 and over”/
19. exp health services for the aged/
20. (old$ adj5 (age$ or people or person$)).tw.
21. (geriatric$ or elderly or senior$).tw.
22. or/17-21
23. exp eye diseases/
24. exp visual acuity/
25. exp macular degeneration/
26. macula$ degenerat$.tw.
27. (eye$ or vision or ophthalmic or glaucom$ or cataract$ or presbyop$).tw.
28. or/23-27
29. 16 and 22 and 28
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30. 12 and 29
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville et al (Glanville 2006).
Appendix 3. EMBASE search strategy
1. exp randomized controlled trial/
2. exp randomization/
3. exp double blind procedure/
4. exp single blind procedure/
5. random$.tw.
6. or/1-5
7. (animal or animal experiment).sh.
8. human.sh.
9. 7 and 8
10. 7 not 9
11. 6 not 10
12. exp clinical trial/
13. (clin$ adj3 trial$).tw.
14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15. exp placebo/
16. placebo$.tw.
17. random$.tw.
18. exp experimental design/
19. exp crossover procedure/
20. exp control group/
21. exp latin square design/
22. or/12-21
23. 22 not 10
24. 23 not 11
25. exp comparative study/
26. exp evaluation/
27. exp prospective study/
28. (control$ or prospectiv$ or volunteer$).tw.
29. or/25-28
30. 29 not 10
31. 30 not (11 or 23)
32. 11 or 24 or 31
33. exp vision test/
34. ((vision or visual$) adj5 (screen* or assess* or test* or diagnos* or surveill*)).tw.
35. or/33-34
36. exp aged/
37. exp senescence/
38. exp elderly care/
39. (old$ adj5 (age$ or people or person$)).tw.
40. (geriatric$ or elderly or senior$).tw.
41. or/36-40
42. exp eye disease/
43. exp visual acuity/
44. exp retina macula degeneration/
45. macula$ degenerat$.tw.
46. (eye$ or vision or ophthalmic or glaucom$ or cataract$ or presbyop$).tw.
47. or/42-46
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48. 35 and 41 and 47
49. 32 and 48
Appendix 4. UK Clinical Trials Gateway search strategy
(screen% OR test% OR assess%) AND (vision)
Appendix 5. PubMed search strategy
((old age*) OR (geriatric* OR elderly OR senior*)) AND (screening* OR assessment* OR diagnoses OR diagnosis OR diagnosing OR
test OR tests OR testing) AND (eye* OR cataract* OR glaucom* OR vision* OR presbyop*) AND (randomized controlled trial [pt]
OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh]
OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh]) OR (“clinical trial” [tw]) OR ((singl* [tw] OR doubl*
[tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw]
OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective
studies [mh]) NOT (animals [mh] NOT human [mh])
WH A T ’ S N E W
Last assessed as up-to-date: 23 April 2008.
Date Event Description
9 May 2008 New search has been performed Electronic searches have been updated and one new study is awaiting assessment
23 April 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 1, 1998
Review first published: Issue 3, 1998
Date Event Description
2 March 2006 New citation required and conclusions have changed Substantive amendment
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